TOKYO - FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announces the investment of USD 200 million in two subsidiaries to significantly expand global cell therapy contract development and manufacturing (CDMO) capabilities. The investment will enable Fujifilm to support the expanding cell therapy market which is anticipated to grow by more than 30% per year up from USD 3.3 billion in FY20221. The $200 million investment in cell therapy manufacturing capabilities is earmarked for both the new headquarters of FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cells (iPSC) and iPSC-derived cells, and the California site of FUJIFILM Diosynth Biotechnologies, a world-leading CDMO in biologics and advanced therapies.
Cell therapies are a promising treatment modality with the ability to augment, repair, and/or replace human biology, including organs, tissues and cells. According to Alliance for Regenerative Medicine’s sector data, there are more than 500 ongoing clinical trials for cell therapies globally...
...The investment will fund FUJIFILM Cellular Dynamics’ new 175,000 sq. ft headquarters in Madison, Wisconsin, U.S.A., located in BioMidwest, a hub of life science companies and academia. The new campus located at 8402 Excelsior Drive will house iPSC cGMP3 manufacturing with three clean room suites, process development laboratories, warehouse operations and administrative space. This investment will double the Company’s existing manufacturing capacity for the development and commercialization of iPSC-derived cell therapies for its partners. The new site will also include iPSC manufacturing for research and development applications for drug discovery, drug efficacy, and pharmacology. The full site including cell therapy manufacturing will be operational in spring 2026. ...
...moreRSK: I know it is an older announcement but they have broke ground on Excelsior for the new 175,000 sf headquarters here in Madison.
Share this article on your social outlets
Our Sponsors
- - Volume: 26 - WEEK: 22 Date: 5/26/2026 6:24:01 PM -